Results 91 to 100 of about 21,275,692 (207)

Chinese Expert Consensus on Antiangiogenic Drugs for Advanced Non-small Cell 
Lung Cancer (2019 Edition)

Chinese Journal of Lung Cancer, 2019
Chinese Society of Clinical Oncology, Expert Committee on Vessel Targeted Therapy, Expert Committee on Non-small Cell Lung Cancer, Expert Group on Antiangiogenic Drugs for Non-small Cell Lung Cancer
doaj   +1 more source

Oligometastatic non-small-cell lung cancer: current treatment strategies

, 2016
Patrick J Richard, Ramesh Rengan Department of Radiation Oncology, University of Washington, Seattle, WA, USA Abstract: The oligometastatic disease theory was initially described in 1995 by Hellman and Weichselbaum.
Richard PJ, Rengan R
core  

Non-small cell to small cell lung cancer on PD-1 inhibitors: two cases on potential histologic transformation

, 2018
Nadine Abdallah,1 Misako Nagasaka,2,3 Eman Abdulfatah,4 Dongping Shi,4 Antoinette J Wozniak,2 Ammar Sukari2 1Department of Internal Medicine, Wayne State University, Detroit, MI 48201, USA; 2Department of Oncology, Barbara Ann Karmanos Cancer Institute,
Wozniak AJ, Nagasaka M, Abdulfatah E, Abdallah N, Shi D, Sukari A   +5 more
core  

The effect of health care expenditures on survival in locally advanced and metastatic Non Small Cell Lung Cancer [PDF]

Context: The significant survival benefit of chemotherapy over best supportive care for locally advanced and metastatic NSCLC has been amply demonstrated in the literature.
Paul Rebattu, Lionel Perrier, Frédéric Gomez, Marie-Odile Carrère, Magali Morelle, Nathalie Havet, Bertrand Favier, Anthony Montella, David Pérol   +8 more
core  

GE11-modified liposomes for non-small cell lung cancer targeting: preparation, ex vitro and in vivo evaluation

International Journal of Nanomedicine, 2014
Liang Cheng,1,* Fa-Zhen Huang,1,2,* Li-Fang Cheng,1 Ya-Qin Zhu,1 Qing Hu,1 Ling Li,1 Lin Wei1, Da-Wei Chen1 1Department of Pharmaceutics, College of Pharmaceutical Science, Soochow University, Suzhou, Jiangsu Province, 2Department of Pharmacy, Central ...
Cheng L, Huang FZ, Cheng LF, Zhu YQ, Hu Q, Li L, Wei L, Chen DW   +7 more
doaj  

Validity, reliability and responsiveness of the EORTC QLQ-C30 and the EORTC QLQ-LC13 in Australians with early stage non-small cell lung cancer, CHERE Working Paper 2007/13 [PDF]

Aim: To assess the validity, reliability and responsiveness of two questionnaires, the QLQ-C30 and LC-13, as measures of health-related quality of life (HRQOL) in an Australian sample of people with early stage non-small cell lung cancer.
Michael Boyer, Julie Winstanley, Patsy Kenny, Rosalie Viney, Siggi Zapart, Madeleine King   +5 more
core  

Clinicopathologic Features of NRG1 Fusion-Positive Non-Small Cell Lung Cancer. [PDF]

Genes Chromosomes Cancer
Köylü B, Genç Nİ, Yücel MH, Yıldız A, Aşık E, Kıkılı Cİ, Kemik F, Demir N, Bulutay P, Ölmez ÖF, Selçukbiricik F.   +10 more
europepmc   +1 more source

Advances in Radiotherapy for Neoadjuvant Therapy of Stage III Non-Small Cell Lung Cancer. [PDF]

Cancer Sci
Mao Q, Yu Y, Fang Y, Zhu S, Tang C, Cai J.   +5 more
europepmc   +1 more source

Myeloperoxidase promotes a tumorigenic microenvironment in non-small cell lung cancer. [PDF]

Redox Biol
Valadez-Cosmes P, Maitz K, Lagler A, Kindler O, Mujkanovic NC, Raftopoulou S, Kienzl M, Juvan ZN, Santiso A, Brcic L, Gorkiewicz G, Lindenmann J, Sattler W, Heinemann A, Schicho R, Marsche G, Houghton AM, Kargl J.   +17 more
europepmc   +1 more source

Restoring expression of tumour suppressor PTEN by engineered circular RNA‐enhanced Osimertinib sensitivity in non‐small cell lung cancer

Clinical and Translational Medicine
Haoran Li, Zheng Liu, Shaoyi Chen, Jingsheng Cai, Peiyu Wang, Kezhong Chen, Mantang Qiu   +6 more
doaj   +1 more source